MEDICAL

TECHNOLOGIES

Microlyte®

Bioresorbable Matrix

Available via both Spartan Medical’s

Supporting Product Literature:

Next Generation Antimicrobial Matrix

Microlyte® Matrix absorbs wound fluid and transforms into a bioresorbable gel that intimately contours to the underlying wound bed. It maintains a physiologically moist microenvironment. In vitro and in vivo, studies indicate that components of the matrix allow cell growth and neovascularization. 1,2,3

 

  • Bioresorbable Matrix: 100% bioresorbable polymer matrix eliminates the need to remove residual matrix from the wound 2
  • Contours to Wound Bed: Absorbs wound fluid and serves as scaffold for cell migration, vascularization, granulation tissue formation1,2.
  • Transparent & Synthetic: Allows for clear view of wound bed, isn’t of human or animal origin, and holds a long room-temp. shelf life 6
  • Low Residual Toxicity: Less wound staining and needs only ˜1 µg/cm² Ag+ to kill microbes on the tissue surface 7

Clinically-Proven

Thirty-two patients with a total of 35 chronic, nonhealing wounds of varying types were treated with Microlyte® Matrix once every three days.  At 3 weeks, 72% of wounds had significantly improved healing with an average wound area reduction of 66%. By 12 weeks, 91% of wounds either healed completely or improved significantly with an average wound area reduction of 73%.  The application of Microlyte® Matrix was safe and well tolerated, and it facilitated improvements in healing of a majority of the complex chronic wounds studied.  Click Here to read the full article from the November issue of WOUNDS.

 

REFERENCES 1 A Agarwal, et al. Biomaterials, 31 (4), 680-690, 2010. 2 Systemic Toxicity, Local Tissue Response, and Wound Healing Study of Microlyte Ag wound dressing, Following Repeated Treatment to Full-Thickness Wounds in Rats – 28 Days. Study 15T_41113_02, 2015. Data on file, Imbed Biosciences. 3 MTT cytotoxicity testing conducted at NAMSA. Data on file at Imbed Biosciences. 4 FDA 510k application. Data on file, Imbed Biosciences. 5 As demonstrated in vitro

 

All necessary regulatory documentation, instructions for use, published studies, patient education tools, etc. (as applicable) can be provided upon request by contacting cs@spartanmedical.com or (888) 240-8091. We are available at any time to meet with Providers and Staff to answer any questions about Spartan Medical’s entire portfolio of advanced medical solutions.

Imbed’s Microlyte Matrix Added to VA’s IDIQ Contract

Imbed’s Microlyte Matrix Added to VA’s IDIQ Contract

Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical®, a veteran-owned Federal Contractor with fourteen years of flawless performance, jointly announced today that Imbed’s Microlyte® Matrix wound dressing portfolio has been added to Spartan Medical’s VA IDIQ Contract with the U.S. Department of Veteran Affairs (VA).

read more
Imbed Biosciences Partners with Spartan Medical® to Provide Advanced Surgical and Wound Care Products to U.S. Veterans and Military Members

Imbed Biosciences Partners with Spartan Medical® to Provide Advanced Surgical and Wound Care Products to U.S. Veterans and Military Members

Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that it has signed a distribution agreement with Spartan Medical®. The distribution agreement will provide customers in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to both Microlyte ® Matrix and Microlyte ® Surgical product lines…

read more